Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Esophageal Neoplasms × Carboplatin × Clear all

Phase

Phase 2 27 Phase 1 13 Phase 3 6 Phase 1/2 6 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 5 Urinary Bladder Neoplasms 4 Ovarian Neoplasms 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Fallopian Tube Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Thymic epithelial tumor 1 Thrombocythemia, Essential 1 Squamous NSCLC 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Retinoblastoma 1 Recurrence 1 Primary Myelofibrosis 1 Primary Malignant Neoplasm of Ovary 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Oropharyngeal Neoplasms 1 Nonsquamous Non-small Cell Lung Cancer 1

Interventions

Cisplatin 7 Radiotherapy 5 Paclitaxel 3 Fluorouracil 3 Capecitabine 3 S 1 (combination) 2 tegafur-gimeracil-oteracil 1 nimotuzumab 1 nedaplatin 1 apatinib 1 TP protocol 1 Surgical Procedures, Operative 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Immunotherapy 1 Fluorodeoxyglucose F18 1 Drug Therapy 1 Cetuximab 1 Carboplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02741856 2018-10-25

SCOPE2

Velindre NHS Trust

Phase 2/3 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡